IRIS
PREZIOSA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.884
EU - Europa 5.508
NA - Nord America 4.873
SA - Sud America 1.164
Continente sconosciuto - Info sul continente non disponibili 609
AF - Africa 145
OC - Oceania 17
Totale 18.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.585
RU - Federazione Russa 3.251
SG - Singapore 2.152
CN - Cina 1.789
BR - Brasile 919
HK - Hong Kong 760
IT - Italia 731
VN - Vietnam 488
SE - Svezia 358
FR - Francia 303
DE - Germania 276
GB - Regno Unito 159
BD - Bangladesh 139
IN - India 124
CA - Canada 113
FI - Finlandia 102
AR - Argentina 98
MX - Messico 83
IR - Iran 59
NL - Olanda 56
TR - Turchia 56
PL - Polonia 55
ZA - Sudafrica 49
EC - Ecuador 48
ES - Italia 46
JP - Giappone 46
IQ - Iraq 42
AT - Austria 41
ID - Indonesia 36
SA - Arabia Saudita 34
CO - Colombia 29
IE - Irlanda 25
EG - Egitto 23
MA - Marocco 21
VE - Venezuela 21
CR - Costa Rica 18
JM - Giamaica 18
LT - Lituania 18
AE - Emirati Arabi Uniti 16
BE - Belgio 16
KE - Kenya 16
MY - Malesia 16
PK - Pakistan 16
PT - Portogallo 16
PY - Paraguay 15
CL - Cile 14
UZ - Uzbekistan 14
AU - Australia 13
IL - Israele 12
TN - Tunisia 12
UA - Ucraina 11
CH - Svizzera 10
NP - Nepal 10
PE - Perù 10
HN - Honduras 9
PR - Porto Rico 8
TT - Trinidad e Tobago 8
JO - Giordania 7
KR - Corea 7
LB - Libano 7
MD - Moldavia 7
UY - Uruguay 7
AZ - Azerbaigian 6
CY - Cipro 6
NO - Norvegia 6
TW - Taiwan 6
AO - Angola 5
BB - Barbados 5
KZ - Kazakistan 5
NG - Nigeria 5
PA - Panama 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
RO - Romania 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GR - Grecia 3
GT - Guatemala 3
KH - Cambogia 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
SV - El Salvador 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GP - Guadalupe 2
NI - Nicaragua 2
QA - Qatar 2
AG - Antigua e Barbuda 1
BF - Burkina Faso 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 17.572
Salva come PNG Salva come JPEG
Città #
Singapore 1.023
Dallas 980
Hong Kong 736
Moscow 723
San Jose 542
Ashburn 540
Council Bluffs 338
Beijing 294
Hefei 252
Shanghai 224
Lauterbourg 220
Ho Chi Minh City 181
Milan 176
New York 171
Los Angeles 121
Hanoi 118
Santa Clara 101
Princeton 97
Lawrence 96
São Paulo 92
Munich 88
Rome 75
Boardman 69
Helsinki 58
Orem 52
Nuremberg 48
Mexico City 43
Chennai 39
Guangzhou 38
Frankfurt am Main 37
Rio de Janeiro 37
Denver 36
Warsaw 36
Tokyo 34
Chicago 33
Boston 31
Montreal 30
Houston 28
Poplar 28
Brooklyn 27
Johannesburg 26
Phoenix 25
Ankara 24
Atlanta 24
Cesano Boscone 24
Da Nang 24
Dublin 24
London 24
Stockholm 24
The Dalles 23
Turku 23
Haiphong 22
Shenzhen 22
Belo Horizonte 21
Manchester 21
Tianjin 21
Tehran 20
Amsterdam 19
Baghdad 19
Buffalo 18
Curitiba 18
Lappeenranta 18
Mumbai 18
Philadelphia 18
Istanbul 17
Naples 17
Toronto 17
Vienna 17
Washington 17
Brasília 16
Guayaquil 16
Las Vegas 16
Charlotte 15
New Delhi 15
Radebeul 15
San José 15
Genoa 14
Hangzhou 14
Miami 14
Pittsburgh 14
Quito 14
Seattle 14
Cairo 13
Biên Hòa 12
Campinas 12
Dhaka 12
Riyadh 12
Brescia 11
Brussels 11
Columbus 11
Nairobi 11
Paris 11
Siena 11
Bologna 10
Buenos Aires 10
Erbil 10
Kuala Lumpur 10
Madrid 10
Medellín 10
Palermo 10
Totale 8.886
Salva come PNG Salva come JPEG
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 366
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 188
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 170
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 163
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 160
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 160
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 155
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 149
Gray matter damage predicts the accumulation of disability 13 years later in MS. 149
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 135
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap 131
Voxel-wise multimodal MRI reveals specific patterns of brain damage in the main multiple sclerosis phenotypes 129
Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis (P1-1.Virtual) 127
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 126
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 126
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 124
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 123
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 123
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 118
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 118
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 117
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 115
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 114
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 113
Resting State Functional Connectivity Correlates of Executive Function in Patients with Multiple Sclerosis 113
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 113
Functional and structural MRI correlates of executive functions in multiple sclerosis 111
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 110
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 101
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 100
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 100
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 98
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 97
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 97
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 97
Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer's disease 97
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 96
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 96
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 95
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 94
Advances in neuroimaging of multiple sclerosis 94
Subventricular Zone Microstructure in Pediatric-Onset Multiple Sclerosis 94
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 93
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 92
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 92
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 90
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 90
Aerobic capacity moderates the association between cervical cord atrophy and clinical disability in mildly disabled multiple sclerosis patients 90
Action observation training modifies brain gray matter structure in healthy adult individuals 90
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 89
Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis 88
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 88
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 87
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 87
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family 87
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis 86
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 86
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 86
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 86
Association between pathological and MRI findings in multiple sclerosis 86
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 85
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 85
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression 85
Clinical relevance of spatial correspondence between regional gene expression and grey matter atrophy in multiple sclerosis 83
Human functional MRI 83
Radiologically isolated syndromes: to treat or not to treat? 82
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 82
Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis 82
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 82
Correspondence between gray matter atrophy and neurotransmitter maps is relevant in multiple sclerosis 81
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 81
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 81
Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders (Journal of Neurology, (2024), 271, 7, (3879-3896), 10.1007/s00415-024-12426-w) 81
Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis 80
Paramagnetic rim lesion burden and choroid plexus enlargement contribute to cognitive impairment and fatigue in multiple sclerosis 80
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 80
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 79
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 78
Artificial Intelligence Applied on Conventional Magnetic Resonance Images Improves the Correct Diagnosis of CNS Diseases Mimicking Multiple Sclerosis 78
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 77
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 77
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 77
Can post-mortem MRI be used as a proxy for in vivo? A case study 76
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 76
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 76
The ageing central nervous system in multiple sclerosis: the imaging perspective 75
Artificial intelligence applied on conventional magnetic resonance images improves the correct diagnosis of CNS diseases mimicking multiple sclerosis 75
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 75
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 74
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 73
Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy 72
Different CSF-in gradients of damage occur in the thalamus, caudate nucleus and cortex in multiple sclerosis: a 3T magnetization transfer ratio and R2*study 71
Clinical integration of brain and cord MRI features improves differential diagnosis of multiple sclerosis 71
Information from ecological momentary assessments leads to over-medicalization: No 71
Quantitative MRI adds to neuropsychiatric lupus diagnostics 70
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD 69
Clinical relevance of multiparametric MRI assessment of spinal cord damage in multiple sclerosis 69
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical Onset 69
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study 68
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 68
Totale 9.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022129 0 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/20253.468 250 97 102 85 124 183 256 357 688 568 287 471
2025/202612.020 914 948 1.052 1.599 834 313 989 849 3.008 801 401 312
2026/20271.011 436 575 0 0 0 0 0 0 0 0 0 0
Totale 18.200